What is the PHQ-9 Depression Screening Tool?

The PHQ-9 is a self-administered instrument based directly on the diagnostic criteria for major depressive disorder. Patients report how often they have been bothered by specific problems over the past two weeks.

Each of the nine items is scored on a scale from 0 to 3:

• 0 – Not at all
• 1 – Several days
• 2 – More than half the days
• 3 – Nearly every day

Because it takes less than three minutes to complete, this screening tool is incredibly efficient for busy medical environments.

How to Score and Interpret the Results

To calculate the final score, simply add the point values of all nine responses together. The total score ranges from 0 to 27. Consequently, higher scores indicate more severe depressive symptoms.

The standard severity thresholds are broken down below:

PHQ-9 Total Score	Depression Severity Level	Recommended Clinical Action
0 – 4	Minimal or none	Monitor; clinical intervention is rarely needed.
5 – 9	Mild	Use clinical judgment; monitor at follow-up.
10 – 14	Moderate	Formulate a treatment plan (therapy or medication).
15 – 19	Moderately severe	Initiate active treatment immediately.
20 – 27	Severe	Urgent intervention; consider specialist referral.

The Tenth Question: Assessing Functional Impact

In addition to the nine core questions, the questionnaire includes a final global clinical question. This asks the patient how difficult these problems have made it to do work, take care of things at home, or get along with other people.

While this final question does not contribute to the numerical score, it provides invaluable context regarding the patient’s functional impairment.

Benefits of Clinical Implementation

Using a standardized tool like the PHQ-9 offers multiple advantages for healthcare providers.

• Objective Tracking: First, it establishes a reliable baseline measurement.
• Progress Monitoring: Second, clinicians can re-administer the test over time to objectively track treatment response.
• High Sensitivity: Finally, research shows it has a 88% sensitivity and 88% specificity for detecting major depression.

In conclusion, incorporating a regular PHQ-9 depression screening protocol streamlines the diagnostic workflow. It ensures that patients receive evidence-based, timely mental health interventions.What is the PHQ-9 Depression Screening Tool?

The PHQ-9 is a self-administered instrument based directly on the diagnostic criteria for major depressive disorder. Patients report how often they have been bothered by specific problems over the past two weeks.

Each of the nine items is scored on a scale from 0 to 3:

• 0 – Not at all
• 1 – Several days
• 2 – More than half the days
• 3 – Nearly every day

Because it takes less than three minutes to complete, this screening tool is incredibly efficient for busy medical environments.

How to Score and Interpret the Results

To calculate the final score, simply add the point values of all nine responses together. The total score ranges from 0 to 27. Consequently, higher scores indicate more severe depressive symptoms.

The standard severity thresholds are broken down below:

PHQ-9 Total Score	Depression Severity Level	Recommended Clinical Action
0 – 4	Minimal or none	Monitor; clinical intervention is rarely needed.
5 – 9	Mild	Use clinical judgment; monitor at follow-up.
10 – 14	Moderate	Formulate a treatment plan (therapy or medication).
15 – 19	Moderately severe	Initiate active treatment immediately.
20 – 27	Severe	Urgent intervention; consider specialist referral.

The Tenth Question: Assessing Functional Impact

In addition to the nine core questions, the questionnaire includes a final global clinical question. This asks the patient how difficult these problems have made it to do work, take care of things at home, or get along with other people.

While this final question does not contribute to the numerical score, it provides invaluable context regarding the patient’s functional impairment.

Benefits of Clinical Implementation

Using a standardized tool like the PHQ-9 offers multiple advantages for healthcare providers.

• Objective Tracking: First, it establishes a reliable baseline measurement.
• Progress Monitoring: Second, clinicians can re-administer the test over time to objectively track treatment response.
• High Sensitivity: Finally, research shows it has a 88% sensitivity and 88% specificity for detecting major depression.

In conclusion, incorporating a regular PHQ-9 depression screening protocol streamlines the diagnostic workflow. It ensures that patients receive evidence-based, timely mental health interventions.